The DOI matches its Crossref record; 148 of the 151 references it cites were found in a registry or an index; 62 of the 97 sources its claims cite were checked for support.
Selection, Comparative Genomics, and Potential Probiotic Features of Escherichia coli 5C, a pks-Negative Strain Isolated from Healthy Infant Donor Feces
Open accessAbstract
Among the emerging issues in probiotic safety, the possible presence of pks, a gene cluster synthetizing a genotoxin known as colibactin, is one of the most alarming. Indeed, indigenous E. coli strain pks-positive are found in 60% of patients with colorectal cancer, and the most widely used E. coli-based probiotic, known as E. coli Nissle 1917 (DSM 6601), is pks-positive. Starting from 25 potential candidates selected by screening 25 infant stool samples, we have selected an E. coli strain (named 5C, deposited as LMG S-33222) belonging to the phylotype A and having the serovar O173:H1. Having been previously completely sequenced by our group, we have further characterized this strain, demonstrating that it is devoid of the most known potential pathogenic-related genes, devoid of possible plasmids, antibiotic-sensitive according to the EFSA panel, resistant in gastric and enteric juice, significantly producing acetate, poorly producing histamine, endowed with a significant in vitro antipathogenic profile, promoting a significant in vitro immunological response based on IL-10 and IL-12, and devoid of the pks genes. A comparative genomics versus E. coli Nissle 1917 is also provided.
Overview
CoChat Summary
## TL;DR
The paper selects an infant-feces-derived *E. coli* strain, 5C (LMG S-33222), that is pks-negative and otherwise shows probiotic-like traits comparable to *E. coli* Nissle 1917. The authors argue that 5C may be a safer *E. coli*-based probiotic because it lacks the pks colibactin cluster while retaining resistance to gastric/intestinal conditions, anti-pathogen activity, and immunomodulatory effects.
## Key findings
- From 25 presumptive *E. coli* isolates recovered from fecal samples of 11 healthy children aged 3 months to 4 years, only 2 strains (5C and 8C) lacked the tested virulence-factor genes; 5C was chosen because 8C carried plasmids with putative virulence factors.
- Strain 5C was reported as antibiotic-sensitive according to EFSA probiotic guidelines and also susceptible to cefixime; its serovar was identified as O173:KNT:H1 and it belonged to phylogroup A.
- Genome analysis found 4,664 genes in 5C, with 4,357 coding sequences, no pks island genes, and no plasmids; a comparative analysis reported 3555 CDS shared with Nissle 1917, 744 CDS unique to 5C, and 82,332 variants versus Nissle 1917.
- In phenotype assays, 5C was said to survive simulated gastric and intestinal juices similarly to Nissle 1917, with higher tolerance at pH 1.8, significant antipathogenic activity against *K. pneumoniae*, *E. cloacae*, and both *S. enterica* serovars tested, and an ability to induce IL-10 and IL-12p70 in hPBMCs.
## Methods
- The study screened fecal samples from 11 healthy children (3 months to 4 years old), isolated 25 presumptive *E. coli* strains on TBX agar, confirmed species identity by 16S rRNA PCR, and removed strains carrying 13 virulence-factor genes before antibiotic testing.
- The selected strains were characterized by whole-genome sequencing, pks detection by BLAST/read mapping and PCR, comparative genomics versus Nissle 1917, prophage detection with PHASTEST, serotyping/phylotyping, and REP-PCR fingerprinting.
- Probiotic-feature assays included simulated gastric/intestinal survival, histamine release, acetate production, adhesion to HT29-MTX cells, antipathogenic co-culture assays, and hPBMC cytokine stimulation (IL-12p70 and IL-10).
## Limitations
- The paper does not report an in vivo efficacy or safety study in animals or humans for strain 5C; this is evident from the methods and results, which are limited to in vitro, genomic, and screening analyses.
- The text makes evident that only one non-pks strain (5C) was selected for deeper study, so conclusions about broader generalizability to other infant-derived *E. coli* isolates are limited; this is an inference from the reported sample and selection design.
- The authors note that pks-negative probiotic development remains an open area: they state that a modified pks-removed Nissle 1917 “has not yet been produced,” which underscores that their comparison is against an existing pks-positive probiotic rather than a finalized engineered alternative.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
33 Valid · 10 Not valid · 17 Not checked · 72 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“the most widely used E. coli-based probiotic, known as E. coli Nissle 1917 (DSM 6601), is pks-positive.”
§ Selection, Comparative Genomics, and Potential Probiotic Features of Escherichia coli 5C, a pks-Negative Strain Isolated from Healthy Infant Donor Feces > Abstract
What the sources say
- Not checked — no full text of the sourcecites [26] Sonnenborn U, Schulze J (2009) The non-pathogenic Escherichia coli strain Nissle 1917 – features of a versatile probiotic. Microbial Ecology in Health and Disease 21:122–158. https://doi.org/10.3109/08910600903444267 source
- Not checked — no full text of the sourcecites [34] Arthur JC (2020) Microbiota and colorectal cancer: colibactin makes its mark. Nat Rev Gastroenterol Hepatol 17(6):317–318. https://doi.org/10.1038/s41575-020-0303-y source
- Not checked — no full text of the sourcecites [35] Pleguezuelos-Manzano C, Puschhhof J, Rosendah Huber A, van Hoeck A, Wood HM, Nomburg J, Gurjao C, Manders F, Dalmasso G, Stege PB, Paganelli FL, Geurts MH, Beumer J, Mizutani T, Miao Y, van der Linden R, van der Elst S, Genomics England Research Consortium, Garcia KC, Top J, Willems RJL, Giannakis MH, Bonnet R, Quirke P, Meyerson M, Cuppen E, van Boxtel H, Clevers H (2020) Mutational signature in colorectal cancer caused by genotoxic pks+ E coli. Nature 580(7802):269–273. https://doi.org/10.1038/s41586-020-2080-8 source
- Could not verifycites [36] Chen B, Ramazzotti D, Heide T, Spiteri I, Fernandez-Mateos J, James C, Magnani L, Graham TA, Sottoriva A (2023) Contribution of pks+ E. coli mutations to colorectal carcinogenesis. Nat Commun 14(1):7827. https://doi.org/10.1038/s41467-023-43329-5 sourceExperimental — accuracy not yet measured
The Introduction says some E. coli strains carry the pks island, and the Results section on pks+ genomic DNA reports detecting pks genes in patient samples. Neither identifies E. coli Nissle 1917 or DSM 6601 as pks-positive; searches for Nissle, DSM 6601, and probiotic did not find a passage establishing that claim. (LLM, conf=0.76)
- Could not verifycites [37] Sogari A, Rovera E, Grasso G, Mariella E, Reilly NM, Lamba S, Mauri G, Durinikova E, Vitiello PP, Lorenzato A, Avolio M, Piumatti E, Bonoldi E, Aquilano MC, Arena S, Sartore-Bianchi A, Siena S, Trusolino L, Donalisio M, Russo M, Di Nicolantonio F, Lembo D, Bardelli A (2024) Tolerance to colibactin correlates with homologous recombination proficiency and resistance to irinotecan in colorectal cancer cells. Cell Rep Med 5(2):101376. https://doi.org/10.1016/j.xcrm.2023.101376 sourceExperimental — accuracy not yet measured
The Introduction says that some E. coli strains harbor the pks island, but does not identify Nissle 1917 as one of them. The References list a paper about the genotoxic activity of Nissle 1917, while the Methods identify a different experimental strain, DH10B pBeloBAC-pks. Searches for Nissle 1917 and DSM 6601 found no passage in our copy stating that Nissle 1917 is pks-positive. (LLM, conf=0.75)
- Could not verifycites [38] Terlouw D, Boot A, Ducarmon QR, Nooij S, Suerink M, van Leerdam ME, van Egmond D, Tops CM, Zwittink RD, Ruano D, Langers AMJ, Nielsen M, van Wezel T, Morreau H (2024) Enrichment of colibactin-associated mutational signatures in unexplained colorectal polyposis patients. BMC Cancer 24(1):104. https://doi.org/10.1186/s12885-024-11849-y sourceExperimental — accuracy not yet measured
The Background discusses pks-bearing E. coli generally, and the Results report pks genes in patient fecal samples. Neither identifies E. coli Nissle 1917 as pks-positive. Searches for “Nissle 1917” and “DSM 6601” found no passage addressing that strain. (LLM, conf=0.75)
- Supportedcites [39] Rosendahl Huber A, Pleguezuelos-Manzano C, Puschhof J, Ubels J, Boot C, Saftien A, Verheul M, Trabut LT, Groenen N, van Roosmalen M, Ouyang KS, Wood H, Quirke P, Meijer G, Cuppen E, Clevers H, van Boxtel R (2024) Improved detection of colibactin-induced mutations by genotoxic E. coli in organoids and colorectal cancer. Cancer Cell 42(3):487-496.e6. https://doi.org/10.1016/j.ccell.2024.02.009 source
The Introduction explicitly states that E. coli Nissle 1917 (EcN) harbors the pks operon in its genome. The Results also include EcN in a panel of pks-positive E. coli strains. Page numbers are not provided in our copy. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“All of them were confirmed to belong to E. coli species by species-specific PCR [50].”
§ Selection, Comparative Genomics, and Potential Probiotic Features of Escherichia coli 5C, a pks-Negative Strain Isolated from Healthy Infant Donor Feces > Results > Species-Specific Identification, Pathogenetic Characterization and Antibiotic Sensitivity Profiles
What the sources say
- Could not verifycites [50] da Silva TF, Glória RA, de Sousa TJ, Americo MF, Freitas ADS, Viana MVC, de Jesus LCL, da Silva Prado LC, Daniel N, Ménard O, Cochet MF, Dupont D, Jardin J, Borges AD, Fernandes SOA, Cardoso VN, Brenig B, Ferreira E, Profeta R, Aburjaile FF, de Carvalho RDO, Langella P, Le Loir Y, Cherbuy C, Jan G, Azevedo V, Guédon É (2023) Comprehensive probiogenomics analysis of the commensal Escherichia coli CEC15 as a potential probiotic strain. BMC Microbiol 23(1):364. https://doi.org/10.1186/s12866-023-03112-4 sourceExperimental — accuracy not yet measured
The Methods (In silico analysis; no page given) describe two E. coli strains used in this study and genomic analysis, not 25 recovered presumptive isolates. Searches for species-specific PCR and isolate identification found no passage confirming that all 25 strains were identified by that method; the paper's RT-qPCR assay addresses a different purpose. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“(iii) antibiotic-sensitive according to the EFSA panel”
§ Selection, Comparative Genomics, and Potential Probiotic Features of Escherichia coli 5C, a pks-Negative Strain Isolated from Healthy Infant Donor Feces > Abstract
What the sources say
- Could not verifycites [66] European Food Safety Authority (EFSA) (2012) Panel on additives and products or substances used in animal feed (FEEDAP) guidance on the assessment of bacterial susceptibility to antimicrobials of human and veterinary importance. EFSA J 10:2740–2750. https://doi.org/10.2903/j.efsa.2012.2740 sourceExperimental — accuracy not yet measured
Section 1.1 defines how the FEEDAP Panel classifies strains as susceptible or resistant using antimicrobial cut-off values. The passages do not assess E. coli 5C specifically; searches for “E. coli 5C” and “Escherichia coli 5C” found no such assessment in our copy. (LLM, conf=0.75)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“versus cefixime, a representative of the cephalosporin class not included in the EFSA panel, the strains resulted to be susceptible according to a set cut-off recently demonstrated [112].”
§ Selection, Comparative Genomics, and Potential Probiotic Features of Escherichia coli 5C, a pks-Negative Strain Isolated from Healthy Infant Donor Feces > Results > Species-Specific Identification, Pathogenetic Characterization and Antibiotic Sensitivity Profiles
What the sources say
- Could not verifycites [112] Zaragoza G, Pérez-Vázquez M, Villar-Gómara L, González-Prieto A, Oteo-Iglesias J, Alós JI (2024) Community emergence of cefixime-resistant Escherichia coli belonging to ST12 with chromosomal AmpC hyperproduction. Antibiotics (Basel) 13(3):218. https://doi.org/10.3390/antibiotics13030218 sourceExperimental — accuracy not yet measured
Section 2.5 reports that the paper’s 23 E. coli isolates were resistant to cefixime; it does not report results for strains 5C, 8C, or Nissle 1917. Section 3.2 says susceptibility was interpreted using existing EUCAST breakpoints, not a newly demonstrated cefixime cut-off. The cited paper therefore cannot verify the susceptibility claim for those strains. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Scientific literature has shown that between 27 and 33% of E. coli detectable in the feces of European newborns are pks-positive [136–138].”
§ Selection, Comparative Genomics, and Potential Probiotic Features of Escherichia coli 5C, a pks-Negative Strain Isolated from Healthy Infant Donor Feces > Discussion > Selection of a Probiotic E. coli Strains Not-Releasing Colibactin
What the sources say
- Not checked — no full text of the sourcecites [136] Nowrouzian F, Hesselmar B, Saalman R, Strannegard IL, Aberg N, Wold AE, Adlerberth I (2003) Escherichia coli in infants’ intestinal microflora: colonization rate, strain turnover, and virulence gene carriage. Pediatr Res 54(1):8–14. https://doi.org/10.1203/01.PDR.0000069843.20655.EE source
- Supportedcites [137] Faïs T, Delmas J, Barnich N, Bonnet R, Dalmasso G (2018) Colibactin: more than a new bacterial toxin. Toxins (Basel) 10(4):151. https://doi.org/10.3390/toxins10040151 source
Section 2.1, “Escherichia coli,” reports that 33% of fecal E. coli tested from Swedish newborns carried the pks island, as did 26.9% of fecal E. coli isolates from healthy French neonates. Rounding 26.9% to 27% supports the stated range. (LLM, conf=0.94)
- Partly supportedcites [138] Secher T, Brehin C, Oswald E (2016) Early settlers: which E. coli strains do you not want at birth? Am J Physiol Gastrointest Liver Physiol 311(1):G123-9. https://doi.org/10.1152/ajpgi.00091.2016 sourceExperimental — accuracy not yet measured
The section ‘Colibactin-Producing E. coli, the Thin Red Line Between Commensalism and Pathogenesis’ (page unavailable) reports pks-positive E. coli colonization in Swedish and French infants at birth. It gives rates of up to 18% and 15% of infants, respectively—not 27–33% of E. coli detected in newborn feces. The populations and denominator therefore do not support the claimed percentage. (LLM, conf=0.84)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
63 more claims · 9 with their cited sources checked
Create a free account to see all 132 claims and to verify the 1 reference still open.
- It may state two separate claims as one. 37
- Probably not a substantial claim. 33
- The quote only partly states this claim. 1
- Not yet classified. 1
Citations
Cites
fastp: an ultra-fast all-in-one FASTQ preprocessor
Chen, S., Zhou, Y., Chen, Y., & Gu, J. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty560 · Cited by 29,721 · cited 1×
“1 [81].”
SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing
Bankevich, A., Nurk, S., Antipov, D., Gurevich, A. A., Dvorkin, M., Kulikov, A. S., Lesin, V. M., Nikolenko, S. I., Pham, S., Prjibelski, A. D., et al. (2012) · Journal of Computational Biology · doi:10.1089/cmb.2012.0021 · Cited by 25,987 · cited 1×
“DNA extraction, library preparation, and in silico genome analysis were performed on the strains according to methods elsewhere described [67–76].”
Wickham, H., Averick, M., Bryan, J., Chang, W., McGowan, L., François, R., Grolemund, G., Hayes, A., Henry, L., Hester, J., et al. (2019) · Journal of Open Source Software · doi:10.21105/joss.01686 · Cited by 22,138
BLAST+: architecture and applications
Camacho, C., Coulouris, G., Avagyan, V., Ma, N., Papadopoulos, J., Bealer, K., & Madden, T. L. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-421 · Cited by 22,074
Prokka: rapid prokaryotic genome annotation
Seemann, T. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu153 · Cited by 18,818
Prodigal: prokaryotic gene recognition and translation initiation site identification
Hyatt, D., Chen, G.-L., LoCascio, P. F., Land, M. L., Larimer, F. W., & Hauser, L. J. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-119 · Cited by 12,587
Parks, D. H., Imelfort, M., Skennerton, C. T., Hugenholtz, P., & Tyson, G. W. (2015) · Genome Research · doi:10.1101/gr.186072.114 · Cited by 12,496
QUAST: quality assessment tool for genome assemblies
Gurevich, A., Saveliev, V., Vyahhi, N., & Tesler, G. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt086 · Cited by 11,172
GTDB-Tk: a toolkit to classify genomes with the Genome Taxonomy Database
Chaumeil, P.-A., Mussig, A. J., Hugenholtz, P., & Parks, D. H. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btz848 · Cited by 5,259
Huerta-Cepas, J., Szklarczyk, D., Heller, D., Hernández-Plaza, A., Forslund, S. K., Cook, H., Mende, D. R., Letunic, I., Rattei, T., Jensen, L. J., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1085 · Cited by 4,902 · cited 1×
“Then, the CDS overlapping any RNA genes were deleted, as they are usually false positive calls [98].”
Versalovic, J., Koeuth, T., & Lupski, R. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.24.6823 · Cited by 3,249 · cited 1×
“…and E. coli 5C was analyzed by Rep-PCR using the (GTG)5 (5 ′ -GTG GTG GTG GTG GTG-3 ′ ) primer and the REP1R-Dt/REP2-Dt couple of primers (REP1R-Dt: 5 ′ -IIINCGNCGNATCNGGC-3 ′ and REP2-Dt: 5 ′ - NCGNCTT ATC NGGC CTA C-3 ′ ) [103] in agreement with the thermal protocol previously described [104].”
CARD 2020: Antibiotic Resistome Surveillance with the Comprehensive Antibiotic Resistance Database
Alcock, B. P., Raphenya, A. R., Lau, T. T. Y., Tsang, K. K., Bouchard, M., Edalatmand, A., Huynh, W., Nguyen, A.-L. V., Cheng, A. A., Liu, S., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz935 · Cited by 3,202 · cited 1×
“The presence of putative AMR genes was ascertained using ABRicate [82] against the following databases: NCBI AMRFinderPlus [83], CARD [84], Resfinder [85], ARG-ANNOT [86], MEGARES [87], and EcOH [88].”
ARAGORN, a program to detect tRNA genes and tmRNA genes in nucleotide sequences
Laslett, D. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh152 · Cited by 2,705 · cited 1×
“Coding sequences (CDS) were parsed with Prodigal [95], tRNAs were found using ARAGORN [96], and rRNAs were annotated using the Infernal command-line tools coupled with the HMM of the bacterial and archaeal rRNAs downloaded from RFAM [97].”
Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN
Morgan, E., Arnold, M., Gini, A., Lorenzoni, V, Cabasag, C. J., Laversanne, M., Vignat, J., Ferlay, J., Murphy, N., & Bray, F. (2023) · Gut · doi:10.1136/gutjnl-2022-327736 · Cited by 2,429 · cited 1×
“Approximately 2 million people are diagnosed with CRC each year, of which 50% succumb to the disease [148].”
Intestinal inflammation targets cancer-inducing activity of the microbiota
Arthur, J. C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J. M., Fan, T.-J., Campbell, B. J., Abujamel, T., Dogan, B., Rogers, A. B., et al. (2012) · Science · doi:10.1126/science.1224820 · Cited by 2,263
Qualimap 2: advanced multi-sample quality control for high-throughput sequencing data
Okonechnikov, K., Conesa, A., & García-Alcalde, F. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btv566 · Cited by 2,145
VFDB 2019: a comparative pathogenomic platform with an interactive web interface
Liu, B., Zheng, D., Jin, Q., Chen, L., & Yang, J. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1080 · Cited by 1,796 · cited 1×
“The databases used for identifying virulence factors were VFDB [89] and E. coli _VF [90].”
Clermont, O., Christenson, J. K., Denamur, E., & Gordon, D. M. (2013) · Environmental Microbiology Reports · doi:10.1111/1758-2229.12019 · Cited by 1,698 · cited 2×
“As regards phylotyping, among the five genes considered in the quadruplex method [108], E. coli 5C matches only with the ArpA gene, therefore belonging to the phylogroup A (Online Resource 14).”
Feldgarden, M., Brover, V., Gonzalez-Escalona, N., Frye, J. G., Haendiges, J., Haft, D. H., Hoffmann, M., Pettengill, J. B., Prasad, A. B., Tillman, G. E., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-91456-0 · Cited by 1,653 · cited 1×
“The presence of putative AMR genes was ascertained using ABRicate [82] against the following databases: NCBI AMRFinderPlus [83], CARD [84], Resfinder [85], ARG-ANNOT [86], MEGARES [87], and EcOH [88].”
Griffiths-Jones, S. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg006 · Cited by 1,594 · cited 2×
“Genes specific to strain E. coli 5C were further analyzed, and functional annotation was performed as described [97].”
BBMerge – Accurate paired shotgun read merging via overlap
Bushnell, B., Rood, J., & Singer, E. (2017) · PLOS ONE · doi:10.1371/journal.pone.0185056 · Cited by 1,544 · cited 1×
“More in detail, reads were mapped using BBMap with a minimum read identity of 99% and excluding reads with secondary alignment [79].”
The population genetics of commensal Escherichia coli
Tenaillon, O., Skurnik, D., Picard, B., & Denamur, E. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2298 · Cited by 1,533 · cited 2×
“However, in consideration of the greater possibility of finding E. coli strains in newborns compared to adults [119, 120], we decided to opt for newborns as a possible source of E. coli .”
ARG-ANNOT, a new bioinformatic tool to discover antibiotic resistance genes in bacterial genomes
Gupta, S. K., Padmanabhan, B. R., Diene, S. M., Lopez-Rojas, R., Kempf, M., Landraud, L., & Rolain, J.-M. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01310-13 · Cited by 1,476 · cited 1×
“The presence of putative AMR genes was ascertained using ABRicate [82] against the following databases: NCBI AMRFinderPlus [83], CARD [84], Resfinder [85], ARG-ANNOT [86], MEGARES [87], and EcOH [88].”
The pros, cons, and many unknowns of probiotics
Suez, J., Zmora, N., Segal, E., & Elinav, E. (2019) · Nature Medicine · doi:10.1038/s41591-019-0439-x · Cited by 1,398
Gut microbiota in colorectal cancer: mechanisms of action and clinical applications
Wong, S. H., & Yu, J. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0209-8 · Cited by 1,331
Kruis, W., Frič, P., Pokrotnieks, J., Lukáš, M., Fixa, B., Kaščák, M., Kamm, M. A., Weismueller, J., Beglinger, C., Stolte, M., et al. (2004) · Gut · doi:10.1136/gut.2003.037747 · Cited by 1,285 · cited 1×
“…characteristics reported above from (i) to (vi) may be considered negative for a probiotic, the strain is widely used, especially (i) in the management of patients diagnosed with ulcerative colitis, but in remission, (ii) in childhood gastroenteritis, and (iii) in adult constipation [26, 41–44].”
Johnson, J. R., & Stell, A. L. (2000) · The Journal of Infectious Diseases · doi:10.1086/315217 · Cited by 1,269 · cited 1×
“…each other phylogenetically among E. coli sensu stricto [107]; that strains responsible for extra-intestinal infection were far more likely to be members of phylogroups B2 than A [143, 144]; and that the B2 phylotype is likely the colibactin-positive most virulent phylogroup among E. coli [145].”
Barnhart, M. M., & Chapman, M. R. (2006) · Annual Review of Microbiology · doi:10.1146/annurev.micro.60.080805.142106 · Cited by 1,227 · cited 1×
“…described as involved in biofilm formation and adhesion (F1A), gut and bladder colonization (F1C), and in bacterial aggregation (Curli) [26, 27]; (ii) having siderophores for iron acquisition (anti-inflammatory and/or fitness factors) [26, 28]; (iii) having O6 repeating units for LPS (a…”
Mutational signature in colorectal cancer caused by genotoxic pks+ E. coli
Pleguezuelos-Manzano, C., Puschhof, J., Rosendahl Huber, A., van Hoeck, A., Wood, H. M., Nomburg, J., Gurjao, C., Manders, F., Dalmasso, G., Stege, P. B., et al. (2020) · Nature · doi:10.1038/s41586-020-2080-8 · Cited by 1,208 · cited 2×
“…in several mouse models, other colibactin-producing E. coli have been observed to promote the development of colorectal cancer [125–131], and human organoids exposed to certain pks -positive E. coli exhibit colibactin-dependent mutational signatures also found in human colorectal cancers [35].”
Fusobacterium nucleatum — symbiont, opportunist and oncobacterium
Brennan, C. A., & Garrett, W. S. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0129-6 · Cited by 1,205 · cited 1×
“Studies on the gut microbiota have recently provided strong evidence of the involvement of intestinal oncobacteria such as F. nucleatum , enterotoxigenic B. fragilis , and pathogenic E. coli strains [149–152].”
Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria
Dejea, C. M., Fathi, P., Craig, J. M., Boleij, A., Taddese, R., Geis, A. L., Wu, X., DeStefano Shields, C. E., Hechenbleikner, E. M., Huso, D. L., et al. (2018) · Science · doi:10.1126/science.aah3648 · Cited by 1,105 · cited 1×
“…strains have been detected in approximately 20% of healthy individuals, 40% of patients with inflammatory bowel disease, and 60% of patients with CRC and are therefore associated with the inflamed and neoplastic mucosa, where they can promote both the onset and progression of CRC [126, 153, 154].”
Diet, microorganisms and their metabolites, and colon cancer
O'Keefe, S. J. D. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.165 · Cited by 1,100
Hemarajata, P., & Versalovic, J. (2013) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x12459294 · Cited by 1,083 · cited 1×
“Numerous studies have demonstrated the beneficial effects deriving from the use of pro-biotics, most frequently attributable to the Bifidobacterium and Lactobacillus species, on human health [5–7].”
Probiotics, Prebiotics, and Synbiotics
de Vrese, M., & Schrezenmeir, J. (2008) · Advances in Biochemical Engineering/Biotechnology · doi:10.1007/10_2008_097 · Cited by 1,028 · cited 1×
“The most investigated E. coli probiotic is the strain Nissle 1917 [123].”
SRST2: Rapid genomic surveillance for public health and hospital microbiology labs
Inouye, M., Dashnow, H., Raven, L.-A., Schultz, M. B., Pope, B. J., Tomita, T., Zobel, J., & Holt, K. E. (2014) · Genome Medicine · doi:10.1186/s13073-014-0090-6 · Cited by 1,004 · cited 1×
“The presence of putative AMR genes was ascertained using ABRicate [82] against the following databases: NCBI AMRFinderPlus [83], CARD [84], Resfinder [85], ARG-ANNOT [86], MEGARES [87], and EcOH [88].”
The infant microbiome development: Mom matters
Mueller, N. T., Bakacs, E., Combellick, J., Grigoryan, Z., & Dominguez-Bello, M. G. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.12.002 · Cited by 943 · cited 2×
“…was a non-pathogenic strain [118], and although the species is abundantly present in most newborns and around 1% in 90% of healthy adults [119, 120], most of what we know about this species comes from studies performed on pathogenic strains, and little is known about which biotic and abiotic…”
Joensen, K. G., Tetzschner, A. M. M., Iguchi, A., Aarestrup, F. M., & Scheutz, F. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.00008-15 · Cited by 915 · cited 3×
“Recent findings have shown that phylotypes A and B2 are the most distant from each other phylogenetically among E. coli sensu stricto [107]; that strains responsible for extra-intestinal infection were far more likely to be members of phylogroups B2 than A [143, 144]; and that the B2 phylotype is…”
Influential(FEEDAP), E. P. O. A. A. P. O. S. U. I. A. F. (2012) · EFSA Journal · doi:10.2903/j.efsa.2012.2740 · Cited by 904
Clustering huge protein sequence sets in linear time
Steinegger, M., & Söding, J. (2018) · Nature Communications · doi:10.1038/s41467-018-04964-5 · Cited by 875 · cited 1×
“All proteins were clustered using MMseqs2 [99] according to 80% identity and 80% coverage; gene families were assigned to “persistent,” “shell,” or “cloud” partitions and saved.”
Health and disease markers correlate with gut microbiome composition across thousands of people
Manor, O., Dai, C. L., Kornilov, S. A., Smith, B., Price, N. D., Lovejoy, J. C., Gibbons, S. M., & Magis, A. T. (2020) · Nature Communications · doi:10.1038/s41467-020-18871-1 · Cited by 816
The Link between Phylogeny and Virulence in Escherichia coli Extraintestinal Infection
Picard, B., Garcia, J. S., Gouriou, S., Duriez, P., Brahimi, N., Bingen, E., Elion, J., & Denamur, E. (1999) · Infection and Immunity · doi:10.1128/iai.67.2.546-553.1999 · Cited by 794 · cited 1×
“…each other phylogenetically among E. coli sensu stricto [107]; that strains responsible for extra-intestinal infection were far more likely to be members of phylogroups B2 than A [143, 144]; and that the B2 phylotype is likely the colibactin-positive most virulent phylogroup among E. coli [145].”
Improved screening procedure for biogenic amine production by lactic acid bacteria
Bover-Cid, S., & Holzapfel, W. H. (1999) · International Journal of Food Microbiology · doi:10.1016/s0168-1605(99)00152-x · Cited by 764 · cited 1×
“…induction before the screening test, E. coli 5C and E. coli Nissle 1917 were subcultured 5 times in Nutrient Standard (Millipore 1,07882; Merck, Darmstadt, Germany) containing 0.1% of histidine monohydrochloride as a precursor amino acid, supplemented with 0.005% of pyridoxal-5-phosphate [109].”
InfluentialThe landscape of somatic mutation in normal colorectal epithelial cells
Lee-Six, H., Olafsson, S., Ellis, P., Osborne, R. J., Sanders, M. A., Moore, L., Georgakopoulos, N., Torrente, F., Noorani, A., Goddard, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1672-7 · Cited by 747 · cited 1×
“It is worth remembering that cancer research suggests that colibactin causes DNA damage early after exposure [157, 158].”
Florensa, A. F., Kaas, R. S., Clausen, P. T. L. C., Aytan-Aktug, D., & Aarestrup, F. M. (2022) · Microbial Genomics · doi:10.1099/mgen.0.000748 · Cited by 695 · cited 1×
“The presence of putative AMR genes was ascertained using ABRicate [82] against the following databases: NCBI AMRFinderPlus [83], CARD [84], Resfinder [85], ARG-ANNOT [86], MEGARES [87], and EcOH [88].”
Matsuki, T., Watanabe, K., Fujimoto, J., Takada, T., & Tanaka, R. (2004) · Applied and Environmental Microbiology · doi:10.1128/aem.70.12.7220-7228.2004 · Cited by 655 · cited 1×
“Firstly, the identification of E. coli species was performed by a specific PCR protocol for the 16S rRNA gene using the primers and conditions previously described [51].”
PHASTEST: faster than PHASTER, better than PHAST
Wishart, D. S., Han, S., Saha, S., Oler, E., Peters, H., Grant, J. R., Stothard, P., & Gautam, V. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad382 · Cited by 647 · cited 2×
“The PHASTEST tool (Phage Search Tool for Escherichia coli ), a freely accessible [100] and user-friendly online tool that can identify and classify prophages and other phage-related sequences in bacterial genomes, was used to detect phage sequences in the E. coli genomes [101].”
Applicability of rep-PCR fingerprinting for identification of Lactobacillus species
Gevers, D. (2001) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(01)00439-6 · Cited by 630 · cited 1×
“…and E. coli 5C was analyzed by Rep-PCR using the (GTG)5 (5 ′ -GTG GTG GTG GTG GTG-3 ′ ) primer and the REP1R-Dt/REP2-Dt couple of primers (REP1R-Dt: 5 ′ -IIINCGNCGNATCNGGC-3 ′ and REP2-Dt: 5 ′ - NCGNCTT ATC NGGC CTA C-3 ′ ) [103] in agreement with the thermal protocol previously described [104].”
van der Ven (2019) · doi:10.12688/f1000research · Cited by 599
Effect of Diet and Dietary Components on the Composition of the Gut Microbiota
Beam, A., Clinger, E., & Hao, L. (2021) · Nutrients · doi:10.3390/nu13082795 · Cited by 576
High Prevalence of Mucosa-Associated E. coli Producing Cyclomodulin and Genotoxin in Colon Cancer
Buc, E., Dubois, D., Sauvanet, P., Raisch, J., Delmas, J., Darfeuille-Michaud, A., Pezet, D., & Bonnet, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056964 · Cited by 535 · cited 1×
“…strains have been detected in approximately 20% of healthy individuals, 40% of patients with inflammatory bowel disease, and 60% of patients with CRC and are therefore associated with the inflamed and neoplastic mucosa, where they can promote both the onset and progression of CRC [126, 153, 154].”
Probiotics Regulate Gut Microbiota: An Effective Method to Improve Immunity
Wang, X., Zhang, P., & Zhang, X. (2021) · Molecules · doi:10.3390/molecules26196076 · Cited by 529
Shiga Toxin (Stx) Classification, Structure, and Function
Melton-Celsa, A. R. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.ehec-0024-2013 · Cited by 525 · cited 1×
“By multiplex PCR, we analyzed the following genes: shiga-like toxin ( stx1 and stx2 ) [52]; intimin A ( eaeA ) found in enterohemorrhagic E. coli (EHEC) [53]; enterohemorrhagic E. coli emolysin (EHEC hlyA ) [54, 55]; verocytotoxins 1 ( vtx1 ) and 2 ( vtx2 ), characteristic of…”
Cougnoux, A., Dalmasso, G., Martinez, R., Buc, E., Delmas, J., Gibold, L., Sauvanet, P., Darcha, C., Déchelotte, P., Bonnet, M., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-305257 · Cited by 486
Emerging issues in probiotic safety: 2023 perspectives
Merenstein, D., Pot, B., Leyer, G., Ouwehand, A. C., Preidis, G. A., Elkins, C. A., Hill, C., Lewis, Z. T., Shane, A. L., Zmora, N., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2185034 · Cited by 481 · cited 1×
“Despite understandable emerging issues in probiotic safety, among probiotics used for both generally healthy consumers and in clinical settings, a few belong to the E. coli species [122].”
Colonization of the Human Gut by E. coli and Colorectal Cancer Risk
Bonnet, M., Buc, E., Sauvanet, P., Darcha, C., Dubois, D., Pereira, B., Déchelotte, P., Bonnet, R., Pezet, D., & Darfeuille-Michaud, A. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1343 · Cited by 475
A distinct Fusobacterium nucleatum clade dominates the colorectal cancer niche
Zepeda-Rivera, M., Minot, S. S., Bouzek, H., Wu, H., Blanco-Míguez, A., Manghi, P., Jones, D. S., LaCourse, K. D., Wu, Y., McMahon, E. F., et al. (2024) · Nature · doi:10.1038/s41586-024-07182-w · Cited by 451 · cited 1×
“Studies on the gut microbiota have recently provided strong evidence of the involvement of intestinal oncobacteria such as F. nucleatum , enterotoxigenic B. fragilis , and pathogenic E. coli strains [149–152].”
The Human Microbiome and Its Impacts on Health
Ogunrinola, G. A., Oyewale, J. O., Oshamika, O. O., & Olasehinde, G. I. (2020) · International Journal of Microbiology · doi:10.1155/2020/8045646 · Cited by 442 · cited 1×
“The gut microbiota plays a central role in maintaining human health and influences digestive, immune, metabolic, and neurological functions, with probable repercussions also in the oncological field [1–3].”
Arthur, J. C., Gharaibeh, R. Z., Mühlbauer, M., Perez-Chanona, E., Uronis, J. M., McCafferty, J., Fodor, A. A., & Jobin, C. (2014) · Nature Communications · doi:10.1038/ncomms5724 · Cited by 392 · cited 1×
“…strains have been detected in approximately 20% of healthy individuals, 40% of patients with inflammatory bowel disease, and 60% of patients with CRC and are therefore associated with the inflamed and neoplastic mucosa, where they can promote both the onset and progression of CRC [126, 153, 154].”
Sonnenborn, U. (2016) · FEMS Microbiology Letters · doi:10.1093/femsle/fnw212 · Cited by 315 · cited 2×
“Currently, the strain, hereafter called E. coli Nissle 1917, or simpler Nissle 1917 or EcN, is deposited at the German Collection for Microorganisms and Cell Cultures (Deutsche Sammlung von Mikroorganismen und Zellkulturen, DSMZ), where it has got the designation E. coli DSM 6601 [25].”
Jerse, A. E., & Kaper, J. B. (1991) · Infection and Immunity · doi:10.1128/iai.59.12.4302-4309.1991 · Cited by 307 · cited 1×
“…1 ( vtx1 ) and 2 ( vtx2 ), characteristic of verocytotoxin-producing E. coli (VTEC) [56]; intimin ( eae ) found in enteropathogenic E. coli (EPEC) [57]; heat-stable ( estA ) and heat-labile enterotoxin ( eltA ), characteristic of enterotoxigenic E. coli (ETEC) [58, 59]; and invasive plasmid…”
Dalmasso, G., Cougnoux, A., Delmas, J., Darfeuille-Michaud, A., & Bonnet, R. (2014) · Gut Microbes · doi:10.4161/19490976.2014.969989 · Cited by 296
PPanGGOLiN: Depicting microbial diversity via a partitioned pangenome graph
Gautreau, G., Bazin, A., Gachet, M., Planel, R., Burlot, L., Dubois, M., Perrin, A., Médigue, C., Calteau, A., Cruveiller, S., et al. (2020) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1007732 · Cited by 274 · cited 1×
“A pangenome analysis of E. coli 5C and E. coli Nissle 1917 was conducted with PPanGGOLiN [94].”
Fagan, P. K., Hornitzky, M. A., Bettelheim, K. A., & Djordjevic, S. P. (1999) · Applied and Environmental Microbiology · doi:10.1128/aem.65.2.868-872.1999 · Cited by 268 · cited 1×
“…( stx1 and stx2 ) [52]; intimin A ( eaeA ) found in enterohemorrhagic E. coli (EHEC) [53]; enterohemorrhagic E. coli emolysin (EHEC hlyA ) [54, 55]; verocytotoxins 1 ( vtx1 ) and 2 ( vtx2 ), characteristic of verocytotoxin-producing E. coli (VTEC) [56]; intimin ( eae ) found in…”
Montassier, E., Valdés-Mas, R., Batard, E., Zmora, N., Dori-Bachash, M., Suez, J., & Elinav, E. (2021) · Nature Microbiology · doi:10.1038/s41564-021-00920-0 · Cited by 256
Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
Tomkovich, S., Yang, Y., Winglee, K., Gauthier, J., Mühlbauer, M., Sun, X., Mohamadzadeh, M., Liu, X., Martin, P., Wang, G. P., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3472 · Cited by 252
A Review of Gut Microbiota‐Derived Metabolites in Tumor Progression and Cancer Therapy
Yang, Q., Wang, B., Zheng, Q., Li, H., Meng, X., Zhou, F., & Zhang, L. (2023) · Advanced Science · doi:10.1002/advs.202207366 · Cited by 240
Patzer, S. I., Baquero, M. R., Bravo, D., Moreno, F., & Hantke, K. (2003) · Microbiology · doi:10.1099/mic.0.26396-0 · Cited by 233 · cited 2×
“As regards to bacteriocin genes, the strain Nissle 1917, besides the already described two microcins, known as M and H47 [31, 32], demonstrates the presence of one colicin and one bottromycin [116], both not pheno-typically expressed.”
The non-pathogenic Escherichia coli strain Nissle 1917 – features of a versatile probiotic
Sonnenborn, U., & Schulze, J. (2009) · Microbial Ecology in Health and Disease · doi:10.3109/08910600903444267 · Cited by 232 · cited 10×
“…(described to make serum-resistant the extra-intestinal pathogenic E. coli strains), and H1-type for flagella (responsible for strain motility) [26, 29, 30]; (iv) having two plasmids (pMUT1 and pMUT2) synthetizing microcins M and H47 (active against Salmonella strains) [26, 31, 32]; (v) being…”
InfluentialEmerging strategies for engineering Escherichia coli Nissle 1917-based therapeutics
Lynch, J. P., Goers, L., & Lesser, C. F. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.02.002 · Cited by 230 · cited 1×
“Since the risk still exists, a “solution” suggested by many authors is the removal of the pks island [134].”
Colibactin: More Than a New Bacterial Toxin
Faïs, T., Delmas, J., Barnich, N., Bonnet, R., & Dalmasso, G. (2018) · Toxins · doi:10.3390/toxins10040151 · Cited by 227
Schwengers, O., Barth, P., Falgenhauer, L., Hain, T., Chakraborty, T., & Goesmann, A. (2020) · Microbial Genomics · doi:10.1099/mgen.0.000398 · Cited by 223
Bonin, N., Doster, E., Worley, H., Pinnell, L. J., Bravo, J. E., Ferm, P., Marini, S., Prosperi, M., Noyes, N., Morley, P. S., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkac1047 · Cited by 215
The efficacy and safety of probiotics in people with cancer: A systematic review
Redman, M. G., Ward, E. J., & Phillips, R. S. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu106 · Cited by 213 · cited 1×
“…safety of using known and extensively tested probiotics [8–10], potential adverse events may occur when they are administered to immunocompromised individuals or to subjects with weakened immune systems, such as pediatric patients, transplant recipients, or patients undergoing chemotherapy [11–14].”
Thiem, V. D., Sethabutr, O., von Seidlein, L., Van Tung, T., Canh, D. G., Chien, B. T., Tho, L. H., Lee, H., Houng, H.-S., Hale, T. L., et al. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.5.2031-2035.2004 · Cited by 211 · cited 1×
“…intimin ( eae ) found in enteropathogenic E. coli (EPEC) [57]; heat-stable ( estA ) and heat-labile enterotoxin ( eltA ), characteristic of enterotoxigenic E. coli (ETEC) [58, 59]; and invasive plasmid antigen ( ipaH ), characteristic of enteroinvasive E. coli (EIEC) and Shigella spp. [60, 61].”
Henker, J., Laass, M., Blokhin, B. M., Bolbot, Y. K., Maydannik, V. G., Elze, M., Wolff, C., & Schulze, J. (2007) · European Journal of Pediatrics · doi:10.1007/s00431-007-0419-x · Cited by 199
Escherichia coli Residency in the Gut of Healthy Human Adults
Martinson, J. N. V., & Walk, S. T. (2020) · EcoSal Plus · doi:10.1128/ecosalplus.esp-0003-2020 · Cited by 197 · cited 1×
“Most non-pathogenic E. coli present in the human intestine belong to phylogroups A, B2, and F [121].”
Advances in Molecular Serotyping and Subtyping of Escherichia coli†
Fratamico, P. M., DebRoy, C., Liu, Y., Needleman, D. S., Baranzoni, G. M., & Feng, P. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00644 · Cited by 194 · cited 1×
“…of strain E. coli 5C, performed with the ECTyper script for the in silico prediction, further validated by the SerotypeFinder for whole-genome sequencing-based O and H typing, gold standard for E. coli serotyping [117], confirmed the presence of the O173 antigen (LPS) and the H1 antigen (flagella).”
Role of Probiotics in Human Health
Bodke, H., & Jogdand, S. (2022) · Cureus · doi:10.7759/cureus.31313 · Cited by 187
Recurrent Septicemia in an Immunocompromised Patient Due to Probiotic Strains of Bacillus subtilis
Oggioni, M. R., Pozzi, G., Valensin, P. E., Galieni, P., & Bigazzi, C. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.1.325-326.1998 · Cited by 178
Nowrouzian, F., Hesselmar, B., Saalman, R., Strannegård, I.-L., Åberg, N., Wold, A. E., & Adlerberth, I. (2003) · Pediatric Research · doi:10.1203/01.pdr.0000069843.20655.ee · Cited by 176 · cited 1×
“Scientific literature has shown that between 27 and 33% of E. coli detectable in the feces of European new-borns are pks-positive [136–138].”
Gao, C., Major, A., Rendon, D., Lugo, M., Jackson, V., Shi, Z., Mori-Akiyama, Y., & Versalovic, J. (2015) · mBio · doi:10.1128/mbio.01358-15 · Cited by 176
Increased somatic mutation burdens in normal human cells due to defective DNA polymerases
Robinson, P. S., Coorens, T. H. H., Palles, C., Mitchell, E., Abascal, F., Olafsson, S., Lee, B. C. H., Lawson, A. R. J., Lee-Six, H., Moore, L., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00930-y · Cited by 173 · cited 1×
“It is worth remembering that cancer research suggests that colibactin causes DNA damage early after exposure [157, 158].”
Bessonov, K., Laing, C., Robertson, J. A., Yong, I., Ziebell, K. A., Gannon, V. P. J., Nichani, A., Arya, G., Nash, J. H. E., & Christianson, S. (2021) · Microbial Genomics · doi:10.1099/mgen.0.000728 · Cited by 172 · cited 1×
“To address the E. coli 5C serotyping determination, we first run the ECTyper script for the in silico prediction [105, 106].”
DNA extract characterization process for microbial detection methods development and validation
Olson, N. D., & Morrow, J. B. (2012) · BMC Research Notes · doi:10.1186/1756-0500-5-668 · Cited by 169 · cited 1×
“DNA extraction, library preparation, and in silico genome analysis were performed on the strains according to methods elsewhere described [67–76].”
Safety Evaluations of Bifidobacterium bifidum BGN4 and Bifidobacterium longum BORI
Kim, M. J., Ku, S., Kim, S. Y., Lee, H. H., Jin, H. Z., Kang, S., Li, R., Johnston, T. V., Park, M. S., & Ji, G. E. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051422 · Cited by 152 · cited 1×
“Although there is consensus on the safety of using known and extensively tested probiotics [8–10], potential adverse events may occur when they are administered to immunocompromised individuals or to subjects with weakened immune systems, such as pediatric patients, transplant recipients, or…”
Interplay between Siderophores and Colibactin Genotoxin Biosynthetic Pathways in Escherichia coli
Martin, P., Marcq, I., Magistro, G., Penary, M., Garcie, C., Payros, D., Boury, M., Olier, M., Nougayrède, J.-P., Audebert, M., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003437 · Cited by 138 · cited 1×
“…Nissle 1917, intestinal epithelial cells showed evidence of DNA damage [132], which was not observed when mice were inoculated with variants of Nissle 1917 carrying mutations in clbA or clbP , genes encoded within the pks cluster and which are directly involved in colibactin synthesis [47, 133].”
A new ferrous iron‐uptake transporter, EfeU (YcdN), from Escherichia coli
Große, C., Scherer, J., Koch, D., Otto, M., Taudte, N., & Grass, G. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05326.x · Cited by 137 · cited 1×
“…(F1C), and in bacterial aggregation (Curli) [26, 27]; (ii) having siderophores for iron acquisition (anti-inflammatory and/or fitness factors) [26, 28]; (iii) having O6 repeating units for LPS (a feature commonly found in extra-intestinal pathogenic E. coli strains), K5-type for capsule…”
Vassiliadis, G., Destoumieux-Garzón, D., Lombard, C., Rebuffat, S., & Peduzzi, J. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00744-09 · Cited by 128 · cited 2×
“As regards to bacteriocin genes, the strain Nissle 1917, besides the already described two microcins, known as M and H47 [31, 32], demonstrates the presence of one colicin and one bottromycin [116], both not pheno-typically expressed.”
The cytotoxic necrotizing factor 1 (CNF1) from Escherichia coli
Boquet, P. (2001) · Toxicon · doi:10.1016/s0041-0101(01)00154-4 · Cited by 123 · cited 1×
“Genes codifying for cnf-1 (cytotoxic necrotizing factor 1), sfa (S fimbriae), and pap (p-associated-pilus) [62, 63] were investigated following the protocol described by Farshad and colleagues [64].”
Rosendahl Huber, A., Pleguezuelos-Manzano, C., Puschhof, J., Ubels, J., Boot, C., Saftien, A., Verheul, M., Trabut, L. T., Groenen, N., van Roosmalen, M., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.02.009 · Cited by 106 · cited 4×
“…31, 32]; (v) being strong bile-resist-ant and colonizing also due to the gene Rfah [26, 33]; and (vi) having the capability of synthetizing and releasing coli-bactin, a mutagenic substance described to promote colo-rectal polyposis and cancer, and reducing cancer response to irinotecan [26, 34–39].”
InfluentialHenker, J., Laass, M. W., Blokhin, B. M., Maydannik, V. G., Bolbot, Y. K., Elze, M., Wolff, C., Schreiner, A., & Schulze, J. (2008) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318169034c · Cited by 100 · cited 1×
“…characteristics reported above from (i) to (vi) may be considered negative for a probiotic, the strain is widely used, especially (i) in the management of patients diagnosed with ulcerative colitis, but in remission, (ii) in childhood gastroenteritis, and (iii) in adult constipation [26, 41–44].”
Enck, P., Zimmermann, K., Menke, G., & Klosterhalfen, S. (2009) · Zeitschrift für Gastroenterologie · doi:10.1055/s-2008-1027702 · Cited by 100 · cited 1×
“Moreover, the strain E. coli A0 34/86, commercially available as Colinfant® New Born (Dyntec, Czech Republic), is mainly used in newborns for preventing infections and atopy [45, 46].”
Mobile antimicrobial resistance genes in probiotics
Tóth, A. G., Csabai, I., Judge, M. F., Maróti, G., Becsei, Á., Spisák, S., & Solymosi, N. (2021) · doi:10.1101/2021.05.04.442546 · Cited by 97
Bäckhed, F., Alsén, B., Roche, N., Ångström, J., von Euler, A., Breimer, M. E., Westerlund-Wikström, B., Teneberg, S., & Richter-Dahlfors, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111640200 · Cited by 96 · cited 1×
“Moreover, only E. coli Nissle 1917 is endowed with F1C fimbria described to allow bacteria to adhere to the urinary tract [147].”
Abdelhamid, A. G., El-Masry, S., & Dougdoug, N. K. E. (2019) · The EPMA Journal · doi:10.1007/s13167-019-00184-z · Cited by 92 · cited 1×
“The ingredients (expressed as g/L) contained in the SIJ composition are pancreatin (1), ox-bile (3), and sodium chloride (9).”
Probiotics: Should All Patients Take Them?
Katkowska, M., Garbacz, K., & Kusiak, A. (2021) · Microorganisms · doi:10.3390/microorganisms9122620 · Cited by 92
Persson, S., Olsen, K. E. P., Scheutz, F., et al. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01692.x · Cited by 89 · cited 1×
“…intimin ( eae ) found in enteropathogenic E. coli (EPEC) [57]; heat-stable ( estA ) and heat-labile enterotoxin ( eltA ), characteristic of enterotoxigenic E. coli (ETEC) [58, 59]; and invasive plasmid antigen ( ipaH ), characteristic of enteroinvasive E. coli (EIEC) and Shigella spp. [60, 61].”
Colibactin-driven colon cancer requires adhesin-mediated epithelial binding
Jans, M., Kolata, M., Blancke, G., D’Hondt, A., Gräf, C., Ciers, M., Sze, M., Thiran, A., Petta, I., Andries, V., et al. (2024) · Nature · doi:10.1038/s41586-024-08135-z · Cited by 84 · cited 2×
“Very recent studies indicate that, in contrast to extremely pathogenic strains like E. coli 11G5, E. coli Nissle 1917 is less oncogenic but may not be considered harmless [155].”
Dore, M. P., Bibbò, S., Fresi, G., Bassotti, G., & Pes, G. M. (2019) · Nutrients · doi:10.3390/nu11122913 · Cited by 83 · cited 1×
“Sometimes, intestinal discomfort may also occur, which is generally transient and decreases as the microbiota adapts [15].”
Nougayrède, J.-P., Chagneau, C. V., Motta, J.-P., Bossuet-Greif, N., Belloy, M., Taieb, F., Gratadoux, J.-J., Thomas, M., Langella, P., & Oswald, E. (2021) · mSphere · doi:10.1128/msphere.00624-21 · Cited by 82 · cited 2×
“…with their efficacy; (iii) be involved in the production and metabolism of histamine (potentially promoting intestinal inflammatory response); or (iv) be associated with the transmission of antibiotic resistance elements or with the production of genotoxic metabolites, such as colibactin [16–23].”
Contribution of pks+ E. coli mutations to colorectal carcinogenesis
Chen, B., Ramazzotti, D., Heide, T., Spiteri, I., Fernandez-Mateos, J., James, C., Magnani, L., Graham, T. A., & Sottoriva, A. (2023) · Nature Communications · doi:10.1038/s41467-023-43329-5 · Cited by 74
Lactobacillus rhamnosus GG cell-free supernatant as a novel anti-cancer adjuvant
Salemi, R., Vivarelli, S., Ricci, D., Scillato, M., Santagati, M., Gattuso, G., Falzone, L., & Libra, M. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04036-3 · Cited by 72 · cited 1×
“Although there is consensus on the safety of using known and extensively tested probiotics [8–10], potential adverse events may occur when they are administered to immunocompromised individuals or to subjects with weakened immune systems, such as pediatric patients, transplant recipients, or…”
Sever Sepsis After Probiotic Treatment With Escherichia coli NISSLE 1917
Guenther, K., Straube, E., Pfister, W., Guenther, A., & Huebler, A. (2010) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181c36eb9 · Cited by 63 · cited 1×
“This strain has been used for over a century with few reports of adverse events reported in the literature [124].”
Bottromycins - biosynthesis, synthesis and activity
Franz, L., Kazmaier, U., Truman, A. W., & Koehnke, J. (2021) · Natural Product Reports · doi:10.1039/d0np00097c · Cited by 62 · cited 1×
“As regards to bacteriocin genes, the strain Nissle 1917, besides the already described two microcins, known as M and H47 [31, 32], demonstrates the presence of one colicin and one bottromycin [116], both not pheno-typically expressed.”
Anaphylactic reaction to probiotics. Cow’s milk and hen’s egg allergens in probiotic compounds
Martín‐Muñoz, M. F., Fortuni, M., Caminoa, M. J., Belver, M. T., Quirce, S., & Caballero, T. (2012) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.2012.01338.x · Cited by 59 · cited 1×
“…with their efficacy; (iii) be involved in the production and metabolism of histamine (potentially promoting intestinal inflammatory response); or (iv) be associated with the transmission of antibiotic resistance elements or with the production of genotoxic metabolites, such as colibactin [16–23].”
Early settlers: which E. coli strains do you not want at birth?
Secher, T., Brehin, C., & Oswald, E. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00091.2016 · Cited by 58 · cited 1×
“Scientific literature has shown that between 27 and 33% of E. coli detectable in the feces of European new-borns are pks-positive [136–138].”
Rahdar, M., Rashki, A., Miri, H., & Ghalehnoo, M. R. (2015) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.22647 · Cited by 55 · cited 1×
“Genes codifying for cnf-1 (cytotoxic necrotizing factor 1), sfa (S fimbriae), and pap (p-associated-pilus) [62, 63] were investigated following the protocol described by Farshad and colleagues [64].”
Strong pathogen competition in neonatal gut colonisation
Mäklin, T., Thorpe, H. A., Pöntinen, A. K., Gladstone, R. A., Shao, Y., Pesonen, M., McNally, A., Johnsen, P. J., Samuelsen, Ø., Lawley, T. D., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35178-5 · Cited by 54 · cited 1×
“High-resolution shotgun metagenomic screening of newborns in the UK has shown that pks -island-carrying E. coli of the B2 phylotype frequently colonize as early as the first 15 days of life [159].”
Weiteres über Grundlagen und Praxis der Mutaflorbehandlung
Nissle, A. (1925) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0028-1137292 · Cited by 50 · cited 1×
“Indeed, he isolated from a stool sample of him a strain of E. coli that, in laboratory tests, demonstrated antagonistic activity towards other intestinal pathogens [24, 25].”
Weerdenburg, E., Davies, T., Morrow, B., Zomer, A. L., Hermans, P., Go, O., Spiessens, B., van den Hoven, T., van Geet, G., Aitabi, M., et al. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciac421 · Cited by 49 · cited 2×
“…to make serum-resistant the extra-intestinal pathogenic E. coli strains), and H1-type for flagella (responsible for strain motility) [26, 29, 30]; (iv) having two plasmids (pMUT1 and pMUT2) synthetizing microcins M and H47 (active against Salmonella strains) [26, 31, 32]; (v) being strong…”
Joffré, E., von Mentzer, A., Svennerholm, A., et al. (2016) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2016.05.016 · Cited by 48 · cited 1×
“…intimin ( eae ) found in enteropathogenic E. coli (EPEC) [57]; heat-stable ( estA ) and heat-labile enterotoxin ( eltA ), characteristic of enterotoxigenic E. coli (ETEC) [58, 59]; and invasive plasmid antigen ( ipaH ), characteristic of enteroinvasive E. coli (EIEC) and Shigella spp. [60, 61].”
Pei, Z., Liu, Y., Chen, Y., Pan, T., Sun, X., Wang, H., Ross, R. P., Lu, W., & Chen, W. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2309684 · Cited by 48 · cited 2×
“…prophages, useful in providing a substantial collection of reference sequences for forthcoming human gut phageome-related investigations and potentially enabling better risk assessment of prophage dissemination [142], E. coli is one of the bacterial species with the higher prevalence of prophages.”
Agin, T. S., Cantey, J. R., Boedeker, E. C., et al. (1996) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1996.tb08538.x · Cited by 45 · cited 1×
“…PCR, we analyzed the following genes: shiga-like toxin ( stx1 and stx2 ) [52]; intimin A ( eaeA ) found in enterohemorrhagic E. coli (EHEC) [53]; enterohemorrhagic E. coli emolysin (EHEC hlyA ) [54, 55]; verocytotoxins 1 ( vtx1 ) and 2 ( vtx2 ), characteristic of verocytotoxin-producing E.…”
Krammer, H. J., Kämper, H., von Bünau, R., Zieseniß, E., Stange, C., Schlieger, F., Clever, I., & Schulze, J. (2006) · Zeitschrift für Gastroenterologie · doi:10.1055/s-2006-926909 · Cited by 42
Mancabelli, L., Tarracchini, C., Milani, C., Lugli, G. A., Fontana, F., Turroni, F., van Sinderen, D., & Ventura, M. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.08.028 · Cited by 39 · cited 1×
“Another average, for 15% of the entire gut microbiota and up to 40% in some subjects [135].”
Mikucka, A., Deptuła, A., Bogiel, T., Chmielarczyk, A., Nurczyńska, E., & Gospodarek-Komkowska, E. (2022) · Pathogens · doi:10.3390/pathogens11090977 · Cited by 38
Cupriavidus and Burkholderia species associated with agricultural plants that grow in alkaline soils
Santos, P. E. L., Vacaseydel-Aceves, N. B., Martínez‐Aguilar, L., et al. (2011) · The Journal of Microbiology · doi:10.1007/s12275-011-1127-9 · Cited by 35 · cited 1×
“We performed Rep-PCR reactions using BoxAR1 (5 ′ - CTA CGG CAA GGC GAC CTG ACG-3 ′ ) using thermal cycles and PCR conditions following the method described by Estrada et al. [102].”
PROBIOTIC GASTROINTESTINAL ALLERGIC REACTION CAUSED BY SACCHAROMYCES BOULARDII
Hwang, J., Kang, K. J., Kang, Y. N., & Kim, A. S. (2009) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)60154-8 · Cited by 32
From Escherich to the Escherichia coli genome
Méric, G., Hitchings, M. D., Pascoe, B., & Sheppard, S. K. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30066-4 · Cited by 32 · cited 1×
“Although the first E. coli ever isolated (by T. Escherich in 1885, today known as strain NCTC86) was a non-pathogenic strain [118], and although the species is abundantly present in most newborns and around 1% in 90% of healthy adults [119, 120], most of what we know about this species comes from…”
Microbiota and colorectal cancer: colibactin makes its mark
Arthur, J. C. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0303-y · Cited by 30 · cited 1×
“…31, 32]; (v) being strong bile-resist-ant and colonizing also due to the gene Rfah [26, 33]; and (vi) having the capability of synthetizing and releasing coli-bactin, a mutagenic substance described to promote colo-rectal polyposis and cancer, and reducing cancer response to irinotecan [26, 34–39].”
Messens, W., BOLTON, D., Frankel, G. M., Liébana, E., McLauchlin, J., Morabito, S., Oswald, É., & Threlfall, E. J. (2014) · Epidemiology and Infection · doi:10.1017/s095026881400137x · Cited by 28 · cited 1×
“…E. coli emolysin (EHEC hlyA ) [54, 55]; verocytotoxins 1 ( vtx1 ) and 2 ( vtx2 ), characteristic of verocytotoxin-producing E. coli (VTEC) [56]; intimin ( eae ) found in enteropathogenic E. coli (EPEC) [57]; heat-stable ( estA ) and heat-labile enterotoxin ( eltA ), characteristic of…”
Johnsen, N., Hamilton, A., Greve, A., Christensen, M. G., Therkildsen, J. R., Wehmöller, J., Skals, M., & Prætorius, H. A. (2019) · Cellular Microbiology · doi:10.1111/cmi.13017 · Cited by 27 · cited 1×
“…toxin ( stx1 and stx2 ) [52]; intimin A ( eaeA ) found in enterohemorrhagic E. coli (EHEC) [53]; enterohemorrhagic E. coli emolysin (EHEC hlyA ) [54, 55]; verocytotoxins 1 ( vtx1 ) and 2 ( vtx2 ), characteristic of verocytotoxin-producing E. coli (VTEC) [56]; intimin ( eae ) found in…”
Dubbert, S., Klinkert, B., Schimiczek, M., Wassenaar, T. M., & Bünau, R. V. (2020) · European Journal of Microbiology and Immunology · doi:10.1556/1886.2019.00025 · Cited by 24 · cited 2×
“Nissle 1917 was initially thought not to be genotoxic [131].”
Tariq, H., Noreen, Z., Ahmad, A., Khan, L., Ali, M., Malik, M., Javed, A., Rasheed, F., Fatima, A., Kocagoz, T., et al. (2022) · PLOS ONE · doi:10.1371/journal.pone.0262662 · Cited by 22 · cited 1×
“…each other phylogenetically among E. coli sensu stricto [107]; that strains responsible for extra-intestinal infection were far more likely to be members of phylogroups B2 than A [143, 144]; and that the B2 phylotype is likely the colibactin-positive most virulent phylogroup among E. coli [145].”
Mäklin, T., Taira, A., Arredondo-Alonso, S., Shao, Y., Stratton, M. R., Lawley, T. D., Aaltonen, L. A., & Corander, J. (2025) · The Lancet Microbe · doi:10.1016/j.lanmic.2024.101015 · Cited by 22
Transcriptional regulation through RfaH contributes to intestinal colonization by Escherichia coli
Nagy, G., Dobrindt, U., Grozdanov, L., Hacker, J., & EmÅdy, L. (2005) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2005.01.038 · Cited by 20 · cited 2×
“As regards the gene rfaH , a transcriptional regulation factor enhancing the colonizing capability of E. coli strains and their capability to resist bile salts [26, 33], the strain E. coli 5C was found to have it.”
Duggett, N. A., Ellington, M. J., Hopkins, K. L., et al. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa407 · Cited by 20 · cited 1×
“Noteworthy, this last allele found in strain Nissle 1917 is described as a possible pathogenic feature found in antibiotic-resistant E. coli [115].”
Genetic and Functional Analysis of the pks Gene in Clinical Klebsiella pneumoniae Isolates
Luo, C., Chen, Y., Hu, X., Chen, S., Lin, Y., Liu, X., & Yang, B. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.00174-23 · Cited by 20
Shi, Q., Quan, J., Lan, P., Huang, D., Zhou, J., Jiang, Y., & Yu, Y. (2020) · Epidemiology and Infection · doi:10.1017/s0950268820000655 · Cited by 17 · cited 1×
“…and to evaluate its possible presence in DSM 17252, we have respectively analyzed the bacterial cells contained in Colinfant® New Born and the mixture of E. coli strains (G1/2, G3/10, G4/9, G5, G6/7, G8) contained in Symbi-oflor® 2 through PCR, according to the method described previously [110].”
Sogari, A., Rovera, E., Grasso, G., Mariella, E., Reilly, N. M., Lamba, S., Mauri, G., Durinikova, E., Vitiello, P. P., Lorenzato, A., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101376 · Cited by 17
Zschüttig, A., Auerbach, C., Meltke, S., Eichhorn, C., Brandt, M., Blom, J., Goesmann, A., Jarek, M., Scharfe, M., Zimmermann, K., et al. (2015) · Genome Announcements · doi:10.1128/genomea.01330-14 · Cited by 16 · cited 1×
“As regards the E. coli mixture described before (DSM 17252), it is devoid of potential pathogenic genes, but the information about the gene pks is not precisely reported [49].”
Sheshko, V., Hejnova, J., Rehakova, Z., Sinkora, J., Faldyna, M., Alexa, P., Felsberg, J., Nemcova, R., Bomba, A., & Sebo, P. (2006) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2006.00140.x · Cited by 15 · cited 1×
“Noteworthy, E. coli A0 34/86, a strain apparently devoid of the pks gene [47], contains at least two potential pathogenic genes ( hly , cnf-1 ) respectively responsible for alpha-hemolysin and cytotoxic necrotizing factor-1 production and release [48].”
Terlouw, D., Boot, A., Ducarmon, Q. R., Nooij, S., Suerink, M., van Leerdam, M. E., van Egmond, D., Tops, C. M., Zwittink, R. D., Ruano, D., et al. (2024) · BMC Cancer · doi:10.1186/s12885-024-11849-y · Cited by 15
Rosenberg, S., Bonten, M., Haazen, W., Spiessens, B., Abbanat, D., Go, O., Wagenlehner, F., Shore, N., Hagiwara, Y., Ibarra de Palacios, P., et al. (2021) · Journal of Urology · doi:10.1097/ju.0000000000001425 · Cited by 13 · cited 1×
“As regards serovar, E. coli Nissle 1917 is characterized by an LPS-type, O6, commonly found in extra-intestinal pathogenic E. coli [29, 30, 146].”
Micenková, L., Bosák, J., Smatana, S., Novotný, A., Budínská, E., & Šmajs, D. (2019) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-019-09548-3 · Cited by 12 · cited 1×
“Moreover, the strain E. coli A0 34/86, commercially available as Colinfant® New Born (Dyntec, Czech Republic), is mainly used in newborns for preventing infections and atopy [45, 46].”
Li, D., Li, P., Peng, M., Zhao, X., Jiang, X., Wang, D., Yuan, Y., Guo, Q., Wang, M., Xu, X., et al. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkab489 · Cited by 12
Neumann, B., Lippmann, N., Wendt, S., Karlas, T., Lübbert, C., Werner, G., Pfeifer, Y., & Schuster, C. F. (2022) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-022-00521-7 · Cited by 12 · cited 1×
“It does not encode any known toxins or virulence factors that could harm humans [139].”
Matsumoto, T., Mikamo, H., Ohge, H., Yanagihara, K., Weerdenburg, E., Go, O., Spiessens, B., van Geet, G., van den Hoven, T., Momose, A., et al. (2022) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2022.07.001 · Cited by 11
Identification and characterization of P2-like bacteriophages of Yersinia pestis
Qi, Z., Meng, B., Wei, X., Li, X., Peng, H., Li, Y., Feng, Q., Huang, Y., Zhang, Q., Xu, X., et al. (2022) · Virus Research · doi:10.1016/j.virusres.2022.198934 · Cited by 11 · cited 1×
“The third, the phage fiAA91, is not dangerous for humans or animals as well, showing similar features as HK629 [141].”
da Silva, T. F., Glória, R. D. A., de Sousa, T. J., Americo, M. F., Freitas, A. D. S., Viana, M. V. C., de Jesus, L. C. L., da Silva Prado, L. C., Daniel, N., Ménard, O., et al. (2023) · BMC Microbiology · doi:10.1186/s12866-023-03112-4 · Cited by 11
Onofrei, M. I., Ghiciuc, C. M., Luca, C. M., Postolache, P. A., Sapaniuc, C., Enache-Leonte, G., & Roşu, F. M. (2023) · Medicina · doi:10.3390/medicina59030478 · Cited by 7
Dubbert, S., & von Bünau, R. (2021) · mSphere · doi:10.1128/msphere.00856-21 · Cited by 6 · cited 2×
“In germ-free mice administered with Nissle 1917, intestinal epithelial cells showed evidence of DNA damage [132], which was not observed when mice were inoculated with variants of Nissle 1917 carrying mutations in clbA or clbP , genes encoded within the pks cluster and which are directly involved…”
Zaragoza, G., Pérez-Vázquez, M., Villar-Gómara, L., González-Prieto, A., Oteo-Iglesias, J., & Alós, J.-I. (2024) · Antibiotics · doi:10.3390/antibiotics13030218 · Cited by 5 · cited 1×
“Also, versus cefixime, a representative of the cephalosporin class not included in the EFSA panel, the strains resulted to be susceptible according to a set cut-off recently demonstrated [112].”
Oliveira, G. S., Lentz, S. A., Wink, P. L., & Martins, A. F. (2023) · Future Microbiology · doi:10.2217/fmb-2022-0173 · Cited by 3 · cited 1×
“Phylogenetic placement analysis performed on genes fumC and fimH , both in strain 5C and in strain Nissle 1917, used as control (Online Resource 4), confirmed that the strain E. coli 5C belongs to the E. coli species [114].”
E. coli 5C: a probiotic effective for preventing post-colonoscopy gastrointestinal discomfort?
DI PIERRO, F., CAZZANIGA, M., BERTUCCIOLI, A., PALAZZI, C. M., CAVECCHIA, I., MATERA, M., & ZERBINATI, N. (2026) · Minerva Gastroenterology · doi:10.23736/s2724-5985.24.03772-0 · Cited by 3
Self-citationNaha, A., Cameron, T. A., & Margolin, W. (2025) · Antibiotics · doi:10.3390/antibiotics14010052 · Cited by 3 · cited 1×
“It is not inherently present in all E. coli strains, and it can integrate into the bacterial genome under certain conditions [140].”
Di Pierro, F., Zerbinati, N., Guasti, L., Cazzaniga, M., Bertuccioli, A., Palazzi, C. M., Labrini, E., Sagheddu, V., & Soldi, S. (2024) · Microbiology Resource Announcements · doi:10.1128/mra.00580-24 · Cited by 2 · cited 4×
“PRJNA1114436, and the strain was safely deposited at the LMG-BCCM under the LMG S-33222 number [77].”
InfluentialSelf-citationComplete genome sequences of five Escherichia coli strains with probiotic attributes
Fedrová, P., Hrala, M., Tom, N., Micenková, L., Nascimento, A. M. A., Bosák, J., & Šmajs, D. (2023) · Microbiology Resource Announcements · doi:10.1128/mra.00363-23 · Cited by 1 · cited 2×
“…Nissle 1917, intestinal epithelial cells showed evidence of DNA damage [132], which was not observed when mice were inoculated with variants of Nissle 1917 carrying mutations in clbA or clbP , genes encoded within the pks cluster and which are directly involved in colibactin synthesis [47, 133].”
Research works printed but not linked: 3
- Joffré E, Sjöling Å (2016) The LT1 and LT2 variants of the enterotoxigenic Escherichia coli (ETEC) heat-labile toxin (LT) are associated with major ETEC lineages. Gut Microbes 7(1):75–81. https://doi.org/10.1080/19490976.2015.1127480.Erratum.In:doi:10.1128/JB.02050-14 · doi:10.1080/19490976.2015.1127480.erratum.in:doi:10.1128/jb.02050-14
- Farshad S, Emamghoraishi F, Japoni A (2010) Association of virulent genes hly, sfa, cnf-1 and pap with antibiotic sensitivity in Escherichia coli strains isolated from children with community-acquired UTI. Iran Red Crescent Med J 12:33–37
- Wickham H, Chang W, Henry L, Pedersen TL, Takahashi K, Wilke C, Dunnington D. (2023). RStudio Ggplot2: create elegant data visualisations using The grammar of graphics; 2021. URL https://CRAN.R-project.org/package=ggplot2. R package version, 3(5), 233.
Cited by
Pierro, F. D., Thacharodi, A., Kumaraswami, M., Suvorov, A. N., Zupet, J., & Zerbinati, N. (2026) · Microbial Cell Factories · doi:10.1186/s12934-026-02997-w · Cited by 12
Self-citationBertuccioli, A., Sisti, D., Lazzerini, N., Palazzi, C. M., Zonzini, G. B., Ragazzini, M., & Belli, A. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1604319 · Cited by 7
Self-citationStrain-level resolution is needed to understand the putative pathogenic role of bacteria
Pierro, F. D., Palazzi, C. M., Bertuccioli, A., et al. (2025) · Minerva Medica · doi:10.23736/s0026-4806.25.09792-7
Self-citationHe, Y., 李廷慧, Sun, H., & Yang, J. (2026) · Archives of Microbiology · doi:10.1007/s00203-026-05023-0
Xu, J., Shi, T., Qian, D., Cheng, K., Xu, P., 陈学年, Wang, C., Ru, N., Li, T., Ma, N., et al. (2026) · 中国科学通报:英文版 · doi:10.1016/j.scib.2026.09.052
Metadata
- Authors
- Di Pierro, F., Sagheddu, V., Galletti, S., Casaroli, A., Labrini, E., Soldi, S., Cazzaniga, M., Bertuccioli, A., Matera, M., Cavecchia, I., Palazzi, C. M., Tanda, M. L., & Zerbinati, N.
- Affiliations
- Velleja Research (IT)
- University of Urbino (IT)
- Ospedale Misericordia - Grosseto (IT)
- Ospedale Koelliker (IT)
- University of Insubria (IT)
- Corresponding author
- Palazzi, Chiara Maria
- ORCID
- Venue
- Probiotics and Antimicrobial Proteins
- Published
- 2025-04-16
- Volume
- 18
- Issue
- 1
- Pages
- 436-456
- ISSN
- 1867-1306 (ISSN-L)
- 1867-1314
- PMC
- PMC12999690
- OpenAlex
- W4409506837
- Cited by
- 5
- References
- 151
- Citations by year
- 2026: 3 · 2025: 2
- FWCI
- 2.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Probiotics and Antimicrobial Proteins (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- IrInSubria (University of Insubria) (submittedVersion, cc-by)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- colibactin, probiotic safety, comparative genomics, acetate production, histamine synthesis, antipathogenic activity, IL-10, IL-12, alpha-hemolysin, cytotoxic necrotizing factor 1, probiotic strain selection
- MeSH terms
- Escherichia coli, Feces, Humans, Infant, Peptides, Probiotics, Genomics, Escherichia coli Proteins, Polyketides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.